5,574 Shares in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) Bought by Woodmont Investment Counsel LLC

Woodmont Investment Counsel LLC bought a new position in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund bought 5,574 shares of the company’s stock, valued at approximately $366,000. Woodmont Investment Counsel LLC owned approximately 0.06% of iShares U.S. Pharmaceuticals ETF as of its most recent filing with the Securities and Exchange Commission (SEC).

Several other large investors also recently bought and sold shares of the company. Wealth Enhancement Advisory Services LLC increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 11.0% during the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock worth $253,000 after purchasing an additional 356 shares in the last quarter. Truist Financial Corp raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 46.6% in the fourth quarter. Truist Financial Corp now owns 11,246 shares of the company’s stock worth $739,000 after acquiring an additional 3,576 shares during the last quarter. Jane Street Group LLC raised its holdings in shares of iShares U.S. Pharmaceuticals ETF by 5.5% in the third quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock worth $836,000 after acquiring an additional 616 shares during the last quarter. FMR LLC lifted its position in shares of iShares U.S. Pharmaceuticals ETF by 10.9% in the third quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after acquiring an additional 1,338 shares in the last quarter. Finally, Sequoia Financial Advisors LLC boosted its stake in shares of iShares U.S. Pharmaceuticals ETF by 19.1% during the fourth quarter. Sequoia Financial Advisors LLC now owns 3,433 shares of the company’s stock valued at $226,000 after acquiring an additional 550 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 1.0 %

Shares of IHE stock opened at $70.94 on Tuesday. The company has a market capitalization of $624.27 million, a price-to-earnings ratio of 25.04 and a beta of 0.63. The firm has a 50-day moving average price of $69.95 and a 200 day moving average price of $69.30. iShares U.S. Pharmaceuticals ETF has a twelve month low of $62.68 and a twelve month high of $73.28.

iShares U.S. Pharmaceuticals ETF Company Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.